+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High or low dose steroid therapy for acute renal transplant rejection after prophylactic Okt3 treatment: a prospective randomized study



High or low dose steroid therapy for acute renal transplant rejection after prophylactic Okt3 treatment: a prospective randomized study



Transplant International 5: S437-S439




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067624466

Download citation: RISBibTeXText

DOI: 10.1111/tri.1992.5.s1.437


Related references

High or low dose steroid therapy for acute renal transplant rejection after prophylactic OKT3 treatment: a prospective randomized study. Transplant International 5(Suppl. 1): S437-S439, 1992

A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients. Transplant International 11(3): 231-236, 1998

Randomized prospective study comparing low-dose OKT3 of low-dose antithymocyte globulins for treatment of the first acute rejection of kidney allografts. Nephrology Dialysis Transplantation 11(6): A276, 1996

Pentoxifylline does not prevent cytokine induced first dose reactions following therapy of acute renal transplant rejection with OKT3. Nephrology Dialysis Transplantation 10(6): 1070, 1995

Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients. Transplantation Proceedings 28(3): 1354-1355, 1996

Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection. Transplantation Proceedings 21(1 Pt 2): 1755-1757, 1989

Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients. Transplantation Proceedings 25(4): 2574, 1993

A randomized prospective trial of prophylactic therapy with OKT3 vs ATG-Fresenius after renal transplantation. Journal of the American Society of Nephrology 3(3): 852, 1992

Okt3 treatment of acute renal allograft rejection rjxn resistant to high dose methylprednisolone mp and or anti thymocyte globulin atg. Kidney International 31(1): 456, 1987

The effect of induction alg malg on the outcome of steroid resistant rejection treatment with okt3 in renal transplant patients. Transplantation Proceedings 23(1 BOOK 2): 1039-1040, 1991

A randomized prospective comparison of ALG with OKT3 for treatment of renal vascular rejection. Nephrology Dialysis Transplantation 7(7): 785, 1992

Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection. Transplantation 62(1): 38-42, 1996

Prolonged neurological disability following OKT3 therapy for acute renal transplant rejection. Transplantation 55(3): 677-679, 1993

Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients. Transplantation Proceedings 29(7): 2955-2957, 1997

FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. Transplantation Proceedings 28(6): 3166-3168, 1996